Associated Papers
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.
Zhou Y et al.
Science Advances, 2023
37992168 (PubMed )
Supplement: sciadv.adg2263_tables_s1_to_s5.zip › adg2263_Table_S1.xlsx › Genomic_data
Structural bioinformatics enhances the interpretation of somatic mutations in KDM6A found in human cancers.
Chi YI et al.
Computational and Structural Biotechnology Journal, 2022
35615018 (PubMed )
Supplement: mmc2.xlsx › Sheet1
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung.
Song Z et al.
Cell Death & Disease, 2021
33980813 (PubMed )
Supplement: 41419_2021_3754_MOESM2_ESM.xlsx › Table_S3
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.
Canaani J et al.
Oncotarget, 2020
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Nassar AH et al.
British Journal of Cancer, 2020
31857723 (PubMed )
Supplement: 41416_2019_686_MOESM1_ESM.xlsx › S1.2_Overall_SNV_small_indels
Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study.
Sirohi D et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2018
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.
Chang MT et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2018
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
van Haaften G et al.
Nature Genetics, 2009
19330029 (PubMed )
Supplement: NIHMS30569-supplement-supp_info.pdf
Select a paper to view details